MedTrace Logo

Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2

NCT00180531 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2007-12-13

No results posted yet for this study

Summary

The objective of this study is to evaluate the prevalence of sustained ventricular and supraventricular rhythm disorders in patients implanted with a CONTAK RENEWAL TR2 ventricular resynchronization therapy (CRT) device

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

Renewal TR2

Sponsors & Collaborators

  • Guidant Corporation

    lead INDUSTRY

Principal Investigators

  • P. CHEVALIER, MD · Hôpital Louis Pradel, Lyon

  • S Boveda, MD · Clinique Pasteur

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2007-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180531 on ClinicalTrials.gov